Actively Recruiting
Pilot Observational Study of an Integrative Cure Stay Program
Led by University Hospital, Basel, Switzerland · Updated on 2026-02-09
30
Participants Needed
1
Research Sites
86 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This pilot observational study evaluates the feasibility and acceptability of conducting a prospective study alongside the individualized integrative oncology cure stay program "Via Shalva" for breast and gynecological cancer survivors. The study further explores preliminary changes in patient-reported outcomes, physiological measures, and biological markers before and after the retreat and compared with a matched control group.
CONDITIONS
Official Title
Pilot Observational Study of an Integrative Cure Stay Program
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Breast and gynecological cancer survivors, including ovarian, endometrial, cervical, vulvar, and vaginal cancers, including recurrent disease
- Completed primary cancer treatment (surgery with or without radiation and/or chemotherapy)
- Age 18 years or older
- Ongoing or planned maintenance treatments expected for more than 3 months during the study (e.g., antihormonal therapy, Anti-Her2 antibodies, CDK4/6 inhibitors, Anti-VEGF inhibitors, PARP inhibitors, immune checkpoint inhibitors)
- Signed informed consent for study participation
- Presence of a stoma is allowed
- Prior cancer and prior chemotherapy for any malignant tumor are allowed
- Participation in an experimental therapeutic drug trial allowed
- Use of other complementary therapies, including mistletoe, is allowed
- Pregnancy is allowed
You will not qualify if you...
- Language or cognitive deficits, including impaired consciousness, that make study participation impossible
- Severe physical or psychiatric conditions preventing participation
- Inability to give informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Hospital Basel
Basel, Switzerland, 4031
Actively Recruiting
Research Team
I
Isabell Ge, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here